iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Stopping a GLP-1-based weight-management medicine commonly raises the risk that weight will return, but the amount and timing vary widely. In the SURMOUNT-4 trial, adults who switched from tirzepatide to placebo regained an average 14.0% of their week-36 body weight over the next 52 weeks, while those who continued treatment lost another 5.5%. That result is a population average—not a forecast for one person, every medicine, or every reason for treatment. Blood sugar, blood pressure, lipids, appetite, digestive symptoms, and obesity-related complications may also change, so stopping should be planned with the prescribing clinician.
First, “GLP-1 drug” can mean different medicines
People often use “GLP-1” as shorthand for several medicines used for diabetes or chronic weight management. The exact molecule, dose, indication, treatment duration, and local regulatory label matter when estimating what may happen after discontinuation.
- Semaglutide is a GLP-1 receptor agonist used in different formulations and doses for different indications.
- Tirzepatide activates both GIP and GLP-1 receptors. Calling it simply a GLP-1 drug is common in everyday conversation, but it is pharmacologically a dual GIP/GLP-1 agonist.
- Indications and approved doses differ by product and jurisdiction. A medicine prescribed for type 2 diabetes raises different follow-up issues from one prescribed only for weight management.
Because withdrawal studies do not all use the same medicine or measure the same outcome, percentages should not be compared casually. A percentage of total body weight is not the same as a percentage of weight previously lost.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
What the strongest withdrawal trial found
SURMOUNT-4 design
SURMOUNT-4 was a phase 3 randomized-withdrawal trial published in 2024. It enrolled adults with obesity, or overweight plus a weight-related complication, at 70 sites in Argentina, Brazil, Taiwan, and the United States. Participants did not have diabetes. Everyone first received open-label tirzepatide for 36 weeks and received lifestyle counseling throughout.
#1 Best Overall
- 𝑹𝒆𝒍𝒊𝒂𝒃𝒍𝒆 𝑷𝒓𝒆𝒄𝒊𝒔𝒊𝒐𝒏: With professional expertise refined over 10 years, our brand design ensures accuracy and reliability through high-precision sensor technology
- 𝑬𝒂𝒔𝒚 𝒕𝒐 𝑼𝒔𝒆: The scale is equipped with an easy-to-read display with automatic on/off, low battery, and overload indications. Choose between 2 units of measurement (lb/kg) for your weighing convenience
- 𝑴𝒊𝒏𝒊𝒎𝒂𝒍 𝑫𝒆𝒔𝒊𝒈𝒏: Never Let a scale ruin your style. Place this scale in your bathroom, bedroom, or living room. It will complement the design of your living space
- 𝑨 𝑫𝒖𝒓𝒂𝒃𝒍𝒆 𝑪𝒉𝒐𝒊𝒄𝒆: The scale’s 6-mm tempered glass platform provides exceptional durability and comfort. Equipped with a supportive frame and anti-skid paddings to prevent slipping, you can rely on the sturdiness of our scale
- 𝑳𝒂𝒓𝒈𝒆 𝑷𝒍𝒂𝒕𝒇𝒐𝒓𝒎: Step onto the scale comfortably with its large 11.9 x 11.9-inch platform
Of the 670 people who completed the lead-in and entered randomization, one group continued tirzepatide and the other switched to placebo for another 52 weeks. The trial therefore studied people who tolerated treatment and completed the initial period; it was not a test of abrupt stopping in routine practice.
The reported numbers
| Measure | Continued tirzepatide | Switched to placebo |
|---|---|---|
| Average change during the initial 36-week tirzepatide period | 20.9% mean weight reduction among participants who entered randomization | |
| Mean change from week 36 to week 88 | 5.5% additional mean weight reduction | 14.0% mean regain of week-36 body weight |
| Participants maintaining at least 80% of their lead-in weight loss at week 88 | 89.5% | 16.6% |
The 14.0% figure is a change from the participants’ week-36 body weight during the 52-week withdrawal period. It is not “14% of the weight lost,” and it does not mean that every participant regained all lost weight. The authors concluded that withdrawing tirzepatide led to substantial regain, whereas continued treatment maintained and extended the initial reduction.
What this trial cannot predict
- It did not include people with type 2 diabetes, so it does not answer how stopping should be managed when glucose control is the primary concern.
- It studied tirzepatide, not every semaglutide or other GLP-1-based regimen.
- Participants had already completed 36 weeks of treatment and tolerated it. Their experience may differ from someone stopping after a shorter period or because of side effects.
- The protocol included lifestyle counseling and scheduled follow-up, unlike an unsupervised medication interruption.
- A group average cannot determine an individual’s weight trajectory, appetite, laboratory results, or symptoms.
For perspective only, if a hypothetical person weighed 100 kilograms at week 36, a 14.0% change would correspond to 14 kilograms. That arithmetic illustrates how the trial expressed the result; it is not a prediction for a particular patient.
Rank #2
- 𝗨𝗻𝗺𝗮𝘁𝗰𝗵𝗲𝗱 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻: With 10 years of expertise, we’re trusted by over 5 million customers in 30+ countries. we take pride in our high-precision sensors—the core tech that's responsible for the accuracy in increments down to 0.05 lb
- 𝗪𝗲𝗶𝗴𝗵𝘁 𝗩𝗲𝗿𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗗𝗼𝘂𝗯𝗹𝗲 𝗖𝗵𝗲𝗰𝗸 𝗧𝗲𝗰𝗵: Experience unmatched convenience and accuracy. Simply step on, and the scale quickly checks and ensures precise results—no need to tap or wait for the display to show zero
- 𝗠𝗲𝗮𝘀𝘂𝗿𝗲 𝗟𝗶𝗴𝗵𝘁 𝗜𝘁𝗲𝗺𝘀: Such a versatile scale. Not only can measure your body weight, but also easily weigh items as light as 100g like pets and their food with pinpoint accuracy
- 𝗘𝗮𝘀𝘆 𝘁𝗼 𝗥𝗲𝗮𝗱: Best choice for the elderly. The extra-bright LED display with large and clear numbers make it easy to read for all especially for the seniors, no need bending over or wearing presbyopic glasses
- 𝗨𝘁𝗺𝗼𝘀𝘁 𝗦𝗮𝗳𝗲 𝗮𝗻𝗱 𝗔𝗲𝘀𝘁𝗵𝗲𝘁𝗶𝗰: Expertly designed in California, our stylish scale fits seamlessly in your bedroom/bathroom/home. The sleek round corners, large anti-skid padding, and full-coverage bottom ensure durability and stability
Will weight come back after stopping?
Weight recurrence is a likely risk, not a certainty or a fixed amount. The American Diabetes Association (ADA) states in its 2025 Standards of Care in Overweight and Obesity that clinicians should continue obesity medications after treatment goals when appropriate to maintain health benefits, because discontinuation often results in weight recurrence and worsening or reemergence of cardiometabolic risk factors or obesity-related diseases and complications.
The ADA recommendation does not require every person to stay on one medicine indefinitely. It supports an individualized decision about maintenance, switching, dose changes, or stopping, with monitoring when treatment is withdrawn. A person may stop because of adverse effects, pregnancy planning, cost or access, a change in diagnosis, inadequate benefit, or a shared decision that the balance of benefits and burdens has changed. Each reason calls for a different plan.
What other health changes can occur?
Blood sugar and diabetes management
If the medicine is treating type 2 diabetes, stopping can remove part of the glucose-lowering regimen. The SURMOUNT-4 participants did not have diabetes, so its weight results do not establish a safe diabetes-discontinuation strategy. The prescriber may need to arrange glucose checks and another treatment plan before the last dose rather than waiting for readings to rise.
Rank #3
- ⚖️ 10-Year Accuracy with 4 G-Sensors: Equipped with 4 upgraded G-sensors for ±0.1 lb / 0.05 kg precision, this scale uses two long-lasting AAA batteries to provide stable power and consistent readings. Its optimized circuit design has been tested to deliver reliable accuracy for at least 10 years of daily use—ideal for routine morning weigh-ins and long-term tracking. 2*AAA Batteries Included
- 🔁 Quick kg / lb / st Switching for Everyday Tracking: One-button unit switching makes it easy to compare numbers with gym equipment, fitness apps, or medical checkups. Supports 180 kg / 400 lb / 28 st and fits seamlessly into real daily routines—morning weight checks, intermittent fasting logs, weekly fitness tracking, and shared bathroom use
- ⚡ Instant Step-On Results for Busy Mornings & Night Use: Delivers fast, stable measurements the moment you step on—no tapping, no setup. The bright backlit LED display stays clear during early-morning weigh-ins, low-light bathrooms, post-shower checks, and night-time measurements. Auto-calibration ensures consistency across repeated daily use
- 🛡️ Reinforced Safety Design: Constructed with 6 mm tempered glass, rounded corners, a reinforced internal frame, and an anti-slip base, this scale is designed for long-term durability and daily reliability. Ideal for wet bathroom floors after showers, kids stepping on out of curiosity, seniors checking weight daily, and frequent users during weight-loss cycles
- 🧩 Compact 26 cm Footprint—Fits Small Bathrooms & Modern Spaces: At 10.2 × 10.2 × 0.87 in, this slim digital scale fits under cabinets, next to toilets, in small apartments, dorm bathrooms, home gyms, or bedside wellness setups. The smooth tempered-glass surface wipes clean easily—great for users who weigh in daily, track fitness progress, or maintain long-term health routines
Blood pressure, lipids, and other cardiometabolic measures
Some improvements associated with weight loss or treatment may weaken as weight returns. The ADA specifically warns about worsening or reemergence of cardiometabolic risk factors and obesity-related disease and complications after discontinuation. That warning describes a risk at the population level, not a guarantee that an individual’s blood pressure, glucose regulation, cholesterol, or other measure will change in a particular direction or on a particular schedule.
Obesity-related complications
Conditions affected by body weight can become more difficult to control when weight recurs. Follow-up should therefore address the conditions for which treatment was prescribed, not just the number on a scale. A clinician may review symptoms, laboratory results, blood pressure, sleep-related problems, mobility, or other relevant measures according to the person’s medical history.
What happens to appetite and digestive symptoms?
People commonly ask whether hunger, fullness, nausea, or bowel symptoms change immediately after the last dose. The reviewed evidence does not quantify a reliable timetable or frequency for those changes after stopping.
Rank #4
- Professional Accuracy: With 15 years experience, 20,000+ times reliablility test and advanced patented SaluOptim Tech, this weight scale ensures exceptional precision for your health and fitness
- Optimal Size & Easy-to-Read: With 11.8*11.8 inch platform, you can stand comfortably on your bath scale(Maximum capacity 450lb/205kg). Besides, sleek design, the bright, large LED digital display enables easy reading
- Safe and Durable: Designed with full-coverage base and 6mm tempered glass, the scale is sturdy and durable which is safe for the elderly and children. Also, the 4*AAA batteries included can long last for 18 months
- Special Features: Swithed to Family Mode, the weight of your baby/pet can be calculated automatically by patented Famicare Tech. Besides, light items under 22lb such as packages or pet foods can be measured precisely with the increment down to 0.05lb
- Meet High Standards: The Ovutek scale stands up to the highest standards for everyday users. We genuinely hope to leave you amazed and provide an unforgettable experience
The current United States prescribing information for tirzepatide (Zepbound), revised August 2026, lists nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, fatigue, hair loss, and gastroesophageal reflux disease among common adverse reactions during treatment. That label does not establish how quickly any of these effects resolve after discontinuation. Appetite changes after stopping are plausible concerns, but the available sources do not support promising a specific day, week, or sequence.
Report persistent or troubling symptoms to the prescribing team. Do not assume that a symptom is caused by withdrawal, and do not restart, halve, or substitute doses without medical advice.
How to plan a supervised change
There is no one-size-fits-all taper schedule supported by the evidence summarized here. The safest process is a clinician-guided decision that accounts for the drug, indication, dose, duration, other medicines, and the reason for stopping.
Best Value
- DURABLE ACCURACY CHOICE - Our owned professional factory has been focusing on high quality scales SINCE 2001, we make the digital scale for body weight with best-in-class technology and expertise, and proudly guarantee capacity 400lb/182kg in high 0.1lb/0.05kg division throughout the bathroom scale lifecycle. It helps you to stay fit and monitor your health.
- EASY TO USE - The weight scale is utilized up-to-date digital technology, along with many friendly features, including: auto calibration, auto step-on, auto power off, comfortable platform in 10.9'' x 10.9'', 3*AAA batteries included, 3 units switch: lb/kg/st. Easy for healthy progress or weight loss.
- EASILY VISIBLE LED - The digital scales for body weight are equipped with crystal clear LED in large number size, specially designed for clearly viewing numbers in any conditions, and kept the same brightness throughout batteries' lifecycle.
- EASILY VISIBLE LED - The digital scales for body weight are equipped with crystal clear LED in large number size, specially designed for clearly viewing numbers in any conditions, and kept the same brightness throughout batteries' lifecycle. Whether bodybuilding or just daily fitness, our scale supports your goals.
- BEYOND OUR DIGITAL SCALE - Based on over 20 years focusing on scales, our professional scales digital weight factory has been certified by ISO and Social Accountability for quality and social responsibility. All Vitafit Scale proudly developed and produced by ourselves. All Vitafit products are supported by our US customer service center in the heartland state Missouri. Vitafit: Inspired by Life, for Better Life.
- Contact the prescriber before changing the next dose. Explain whether the goal is to stop, switch, reduce, or pause, and why.
- Confirm which condition is being treated. A weight-management plan may be different from a diabetes plan or treatment for another condition.
- Review alternatives and maintenance options. The clinician may discuss continuing treatment, changing medicines, adjusting the dose, or using another evidence-based approach.
- Set follow-up measurements. Agree on when to check weight trends, glucose if relevant, blood pressure, symptoms, and laboratory tests.
- Decide what would trigger an earlier call. Ask which changes require prompt contact rather than waiting for the next routine appointment.
A planned change is also an opportunity to review nutrition, activity, sleep, mental health, and other factors that support long-term care. These measures complement medical follow-up; they are not proof that weight regain can be prevented for everyone.
Monitoring after discontinuation
Use trends, not a single reading
An optional home scale can help show a trend if weighing is comfortable and clinically appropriate. Record measurements under reasonably similar conditions and look at the pattern over time rather than reacting to one fluctuation. A scale is a monitoring tool, not a diagnostic device or a replacement for follow-up.
Track the measures that match the indication
- For diabetes, follow the glucose-monitoring plan supplied by the care team.
- For hypertension or cardiovascular risk, use the blood-pressure and laboratory schedule your clinician recommends.
- For obesity-related complications, monitor the symptoms and functional measures relevant to that condition.
- Keep a record of appetite, gastrointestinal symptoms, medication changes, and barriers such as access or cost so the next visit can address causes rather than guessing.
What is known about semaglutide withdrawal?
The SURMOUNT-4 publication cites a 2022 extension of the STEP 1 semaglutide trial titled “Weight regain and cardiometabolic effects after withdrawal of semaglutide.” The existence of that publication supports studying withdrawal as a separate question, but the full results were not available in the evidence reviewed for this article. A numerical semaglutide-regain figure should therefore not be borrowed from secondary summaries and presented as though it were established here.
Recommended Free Tools
When comparing withdrawal evidence, check five details: the molecule, the treatment indication, whether participants had diabetes, how long they received treatment before withdrawal, and whether the study randomized them to continue therapy or switch to placebo. Also check whether the reported percentage refers to total body weight or to previously lost weight.
Questions to ask before your last dose
- What is the exact medicine, dose, and indication I am stopping?
- Could stopping affect my diabetes or another condition even if my weight remains stable?
- Do you recommend continuing, switching, or changing the dose instead?
- Which measurements should I record at home, and how often?
- When should I repeat laboratory tests or schedule a follow-up visit?
- Which symptoms or readings should prompt an earlier call?
- If weight starts returning, what is our agreed next step?
The central evidence is consistent: stopping a medicine that has been helping with chronic weight management can allow substantial weight recurrence, while continued treatment can preserve or extend losses in people who remain on it. The size and consequences of that change depend on the individual and the indication, so a prescriber-guided plan and follow-up are more reliable than a do-it-yourself stop or taper.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
